Malnutrition Clinical Trials

Find Malnutrition Clinical Trials Near You

Beneficial Effects of Perfect Heartio Drink in Improving Cardiovascular Health

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Noncommunicable diseases (NCDs) such as type 2 diabetes (T2D) and cardiovascular disease (CVD) account for more deaths globally than any other condition. In 2018, the WHO reported that NCDs accounted for 71% of global deaths. They also showed that low- and middle-income countries are disproportionately affected by NCDs, accounting for 85% of NCD-related deaths among individuals aged 30-69 y. Among NCDs, CVD is the leading and fourth-leading causes of death, accounting for 19.5 million deaths worldwide in 2018. Furthermore, despite increasing global awareness, the prevalence of these conditions continues to increase at alarming rates. Deaths from CVD are expected to reach 23.6 million annually by 2030 from 17.6 million deaths in 2016. The underlying aetiology of these conditions is complex, as they can be influenced by several environmental, genetic, and behavioural factors. However, diet and nutrition play a particularly important role in these conditions, especially in the context of the double burden of malnutrition facing many low- and middle-income countries.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• General healthy subjects during enrolment

• Age 18 and above

• Willing to comply with interventional plan and comes to do follow up

• Willing to gives consent

Locations
Other Locations
Malaysia
UCSI University
RECRUITING
Cheras
Contact Information
Primary
Chung Keat Tan, PhD
cktan@ucsiuniversity.edu.my
0175063305
Time Frame
Start Date: 2025-04-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 55
Treatments
Experimental: Perfect Heartion Drink Interventional Arm
Subjects will be required to consume PH drink for 12 weeks, at the dosage of 15g twice daily. Compliance form will be given to monitor the compliance of subject.
Related Therapeutic Areas
Sponsors
Collaborators: UCSI University
Leads: The Perfect Series Sdn Bhd

This content was sourced from clinicaltrials.gov

Similar Clinical Trials